Annual Short Term Debt
$3.38 M
+$8000.00+0.24%
December 31, 2023
Summary
- As of February 7, 2025, NMRA annual short term debt is $3.38 million, with the most recent change of +$8000.00 (+0.24%) on December 31, 2023.
- During the last 3 years, NMRA annual short term debt has risen by +$2.61 million (+342.15%).
- NMRA annual short term debt is now at all-time high.
Performance
NMRA Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Short Term Debt
$2.75 M
-$862.00 K-23.90%
September 30, 2024
Summary
- As of February 7, 2025, NMRA quarterly short term debt is $2.75 million, with the most recent change of -$862.00 thousand (-23.90%) on September 30, 2024.
- Over the past year, NMRA quarterly short term debt has dropped by -$746.00 thousand (-21.37%).
- NMRA quarterly short term debt is now -23.90% below its all-time high of $3.61 million, reached on June 30, 2024.
Performance
NMRA Quarterly Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Short Term Debt Formula
Short-Term Debt = Current Portion of Long-Term Debt + Short-Term Loans + Commercial Paper + Other Short-Term Borrowings
NMRA Short Term Debt Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +0.2% | -21.4% |
3 y3 years | +342.1% | +5.9% |
5 y5 years | +100.0% | +5.9% |
NMRA Short Term Debt Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | at high | +219.9% | -23.9% | +163.4% |
5 y | 5-year | at high | -100.0% | -23.9% | +259.3% |
alltime | all time | at high | -100.0% | -23.9% | +259.3% |
Neumora Therapeutics Short Term Debt History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $2.75 M(-23.9%) |
Jun 2024 | - | $3.61 M(+3.3%) |
Mar 2024 | - | $3.49 M(+3.3%) |
Dec 2023 | $3.38 M(+0.2%) | $3.38 M(-0.6%) |
Sep 2023 | - | $3.40 M(+2.3%) |
Jun 2023 | - | $3.32 M(-1.4%) |
Dec 2022 | $3.37 M | $3.37 M(+30.1%) |
Date | Annual | Quarterly |
---|---|---|
Jun 2022 | - | $2.59 M(+148.7%) |
Mar 2022 | - | $1.04 M(-1.3%) |
Dec 2021 | $1.06 M(+38.2%) | - |
Dec 2021 | - | $1.06 M(-14.1%) |
Sep 2021 | - | $1.23 M(+60.9%) |
Dec 2020 | $764.00 K(>+9900.0%) | $764.00 K |
Dec 2019 | $0.00 | - |
FAQ
- What is Neumora Therapeutics annual short term debt?
- What is the all time high annual short term debt for Neumora Therapeutics?
- What is Neumora Therapeutics annual short term debt year-on-year change?
- What is Neumora Therapeutics quarterly short term debt?
- What is the all time high quarterly short term debt for Neumora Therapeutics?
- What is Neumora Therapeutics quarterly short term debt year-on-year change?
What is Neumora Therapeutics annual short term debt?
The current annual short term debt of NMRA is $3.38 M
What is the all time high annual short term debt for Neumora Therapeutics?
Neumora Therapeutics all-time high annual short term debt is $3.38 M
What is Neumora Therapeutics annual short term debt year-on-year change?
Over the past year, NMRA annual short term debt has changed by +$8000.00 (+0.24%)
What is Neumora Therapeutics quarterly short term debt?
The current quarterly short term debt of NMRA is $2.75 M
What is the all time high quarterly short term debt for Neumora Therapeutics?
Neumora Therapeutics all-time high quarterly short term debt is $3.61 M
What is Neumora Therapeutics quarterly short term debt year-on-year change?
Over the past year, NMRA quarterly short term debt has changed by -$746.00 K (-21.37%)